Get started
Author

Anja Geerts

OpenAlex ID: A5137099284
Eurotransplant experience with Model for End-Stage Liver Disease standard exceptions for hepatopulmonary syndrome and portopulmonary hypertension
2026 · Maïté Verstraeten, Axel J. T. Jens, et al. · European Respiratory Journal
Corticosteroids in severe alcohol-related hepatitis: A multicenter randomized clinical trial
2026 · Christophe Moreno, Pierre Deltenre, et al. · JHEP Reports
PDF
Harnessing human immune system models to validate NADPH oxidase 1 inhibition as treatment for hepatocellular carcinoma
2026 · Zenzi De Vos, Lander Heyerick, et al. · Frontiers in Pharmacology
PDF
Interleukin-8–driven monocyte activation in primary sclerosing cholangitis: Insights from single-cell analysis and humanized immune system mice
2026 · Lander Heyerick, Zenzi De Vos, et al. · JHEP Reports
Improving quality of life in patients with rare autoimmune liver diseases by structured peer-support (Q.RARE.LI) – A randomized controlled trial across five countries
2026 · Natalie Uhlenbusch, Susan Abbey, et al. · Journal of Psychosomatic Research
SAT-420 Serum glycomics are novel biomakers that increase the prognostic value of the GLOBE score in patients with primary biliary cholangitis
2026 · Xavier Verhelst, Nicky Somers, et al. · Journal of Hepatology
SAT-286 Burden of recurrent primary sclerosing cholangitis (PSC), retransplantation, and explant malignancy in a globally representative cohort of patients of >1500 PSC patients undergoing liver transplant
2026 · Aliya Gulamhusein, Aisha Alawi, et al. · Journal of Hepatology
TOP-295-YI Centrally-imprinted innate immune tolerance following colitis attenuates cholestatic liver disease: implications for gut-liver axis driven PSC-IBD pathogenesis
2026 · Rania Matthys, Lander Heyerick, et al. · Journal of Hepatology
TOP-193-YI Serum glycomics at admission predict liver transplantation-free survival in patients with acetaminophen-induced acute liver failure
2026 · Lorenz Grossar, Nicky Somers, et al. · Journal of Hepatology
OS-092-YI Eurotransplant experience with model for end-stage liver disease standard exceptions for hepatopulmonary syndrome and portopulmonary hypertension
2026 · Maïté Verstraeten, Axel J.T. Jens, et al. · Journal of Hepatology
SAT-505 Development and outcome of ACLF in patients with autoimmune hepatitis, primary biliary cholangitis and primary sclerosing cholangitis compared to patients with non-autoimmune chronic liver disease: analysis of a multicentric international cohort
2026 · Xavier Verhelst, Cristina Sanchez-Garrido, et al. · Journal of Hepatology
FRI-139 Semaglutide provides liver health-related benefits in menopausal women living with MASH: a post hoc analysis of the ESSENCE trial part 1
2026 · Manal F. Abdelmalek, Maria Teresa Arias Loste, et al. · Journal of Hepatology
LBP-026 Hepatic recompensation is associated with sustained transplant-free survival in primary biliary cholangitis decompensated cirrhosis: an international multicenter study from the Global-PBC study group
2026 · Adrielly Martins, Yu Jun Wong, et al. · Journal of Hepatology
SAT-285 Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitis: or just a little bit?
2026 · Lorenz Grossar, Sarah Raevens, et al. · Journal of Hepatology
WED-253 Modeling human innate and adaptive immunity in hepatocellular carcinoma: evaluating anti-IL-8 and anti-PD-L1 immunotherapy in humanized mice
2026 · Zenzi De Vos, Lander Heyerick, et al. · Journal of Hepatology
FRI-182 Semaglutide shows favourable safety across subgroups and a positive hepatic safety profile: findings from ESSENCE part 1
2026 · Philip N. Newsome, Michael Roden, et al. · Journal of Hepatology
Works count: 16
Citation count:
H-index:
I10-index:
Year
Topic
Type